Article
Use of Adult Sensory Panel to Study Individual Differences in the Palatability of a Pediatric HIV Treatment Drug.
Clinical therapeutics - 1 Oct 2017
Mennella Julie A, Mathew Phoebe S, Lowenthal Elizabeth D
Abstract excerpt
PURPOSE: The recommended first-line treatment for young children infected with HIV includes the liquid formulation of the co-formulated protease inhibitors lopinavir/ritonavir (Kaletra® [Abbott Laboratories, Chicago, Illinois]). Clinical reports indicate that some children readily accept the taste of Kaletra, whereas others strongly reject it, which can deter therapeutic adherence and outcomes. METHODS: As a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
